BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12096782)

  • 1. Recipient cells form the intimal proliferative lesion in the rat aortic model of allograft arteriosclerosis.
    Johnson P; Carpenter M; Hirsch G; Lee T
    Am J Transplant; 2002 Mar; 2(3):207-14. PubMed ID: 12096782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging and transplant arteriosclerosis in absence of alloreactivity and immunosuppressive drugs in a rat aortic model: recipient age's contribution.
    Calfa M; Aïtouche A; Vazquez-Padron RI; Gay-Rabinstein C; Lasko D; Badell J; Farji A; El-Haddad A; Liotta C; Louis LB; Simmonds A; Pestana IA; Pang M; Li S; Pham SM
    Transplantation; 2005 Jun; 79(12):1683-90. PubMed ID: 15973169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight fucoidan prevents neointimal hyperplasia after aortic allografting.
    Fréguin-Bouilland C; Alkhatib B; David N; Lallemand F; Henry JP; Godin M; Thuillez C; Plissonnier D
    Transplantation; 2007 May; 83(9):1234-41. PubMed ID: 17496541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
    Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
    Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The origin of neointimal smooth muscle cells in transplant arteriosclerosis from recipient bone-marrow cells in rat aortic allograft.
    Song Z; Li W; Zheng Q; Shang D; Shu X; Guan S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):303-6. PubMed ID: 17641848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated arteriosclerosis in aortic grafts: a role for cytokines in progressive intimal lesion development.
    Geerling RA; Ansari AA; LaFond-Walker AM; Baumgartner WA; Wesselingh S; Herskowitz A
    Transplant Proc; 1998 Jun; 30(4):946-7. PubMed ID: 9636381
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of conversion from cyclosporine A to mizoribine on transplant arteriosclerosis in rat aortic allograft models.
    Shimizu H; Takahashi M; Takeda S; Tahara K; Inoue S; Hakamata Y; Kaneko T; Takeyoshi I; Morishita Y; Kobayashi E
    Microsurgery; 2003; 23(5):454-7. PubMed ID: 14558001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency.
    Onuta G; van Ark J; Rienstra H; Boer MW; Klatter FA; Bruggeman CA; Zeebregts CJ; Rozing J; Hillebrands JL
    Atherosclerosis; 2010 Apr; 209(2):393-402. PubMed ID: 19913790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidonor humoral transfer induces transplant arteriosclerosis in aortic and cardiac graft models in rats.
    Alkhatib B; Freguin-Bouilland C; Litzler PY; Jacquot S; Lallemand F; Henry JP; Thuillez C; Plissonnier D
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):791-7. PubMed ID: 17320586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeyoshi I; Morishita Y; Kobayashi E
    Transpl Immunol; 2004 Nov; 13(3):219-27. PubMed ID: 15381205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.
    Shears LL; Kawaharada N; Tzeng E; Billiar TR; Watkins SC; Kovesdi I; Lizonova A; Pham SM
    J Clin Invest; 1997 Oct; 100(8):2035-42. PubMed ID: 9329968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and indirect effects of alloantibodies link neointimal and medial remodeling in graft arteriosclerosis.
    Thaunat O; Louedec L; Dai J; Bellier F; Groyer E; Delignat S; Gaston AT; Caligiuri G; Joly E; Plissonnier D; Michel JB; Nicoletti A
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2359-65. PubMed ID: 16917106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeuchi K; Takeyoshi I; Morishita Y; Kobayashi E
    Transplantation; 2004 Jun; 77(11):1661-7. PubMed ID: 15201664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated heme oxygenase transfer inhibits graft arteriosclerosis in rat aortic transplants.
    Du D; Chang S; Chen B; Zhou H; Chen ZK
    Transplant Proc; 2007 Dec; 39(10):3446-8. PubMed ID: 18089403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis.
    Hillebrands JL; Klatter FA; van den Hurk BM; Popa ER; Nieuwenhuis P; Rozing J
    J Clin Invest; 2001 Jun; 107(11):1411-22. PubMed ID: 11390423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis.
    Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T; Häyry P
    Arterioscler Thromb; 1991; 11(3):671-80. PubMed ID: 2029505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medial cell apoptosis precedes the development of intimal hyperplasia after transient allogeneic exposure in a rat aortic allograft model of chronic rejection.
    Hare GM; Lee TD; Jordan JL; Hirsch GM
    Transplant Proc; 1999; 31(1-2):1384-5. PubMed ID: 10083612
    [No Abstract]   [Full Text] [Related]  

  • 18. Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosis.
    Religa P; Bojakowski K; Bojakowska M; Gaciong Z; Thyberg J; Hedin U
    Cardiovasc Res; 2005 Feb; 65(2):535-45. PubMed ID: 15639493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Neoral or cyclosporine on the development of chronic rejection in an aortic allograft rat model.
    Little DM; Stoltenberg RL; Hullett DA; Sollinger HW
    Transplant Proc; 1996 Apr; 28(2):880-1. PubMed ID: 8623445
    [No Abstract]   [Full Text] [Related]  

  • 20. Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats.
    Onuta G; Rienstra H; de Boer JF; Boer MW; Roks AJ; Klatter FA; Uges DR; Navis G; Rozing J; Hillebrands JL
    Transplantation; 2007 Aug; 84(4):517-26. PubMed ID: 17713437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.